Company Quick10K Filing
Cosmos Holdings
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-04-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
S-1 2018-10-12 Public Filing
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-17
10-Q 2016-06-30 Filed 2016-08-18
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-20
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-21
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-04-11
10-Q 2013-09-30 Filed 2013-12-09
10-K 2013-07-31 Filed 2013-09-13
10-Q 2013-04-30 Filed 2013-05-13
10-Q 2013-01-31 Filed 2013-03-07
10-Q 2012-10-31 Filed 2012-12-10
10-K 2012-07-31 Filed 2012-10-26
10-Q 2012-04-30 Filed 2012-06-14
10-Q 2012-01-31 Filed 2012-03-16
10-Q 2011-10-31 Filed 2011-12-12
10-K 2011-07-31 Filed 2011-11-02
10-Q 2011-04-30 Filed 2011-06-10
10-Q 2011-01-31 Filed 2011-03-14
10-Q 2010-10-31 Filed 2010-12-15
10-K 2010-07-31 Filed 2010-11-15
10-Q 2010-04-30 Filed 2010-06-14
8-K 2020-03-23 Enter Agreement, Exhibits
8-K 2019-10-23 Enter Agreement, Exhibits
8-K 2019-08-01 Enter Agreement, Exhibits
8-K 2019-07-19 Enter Agreement, Exhibits
8-K 2019-06-24 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-05-28 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-05-15 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2019-04-09 Enter Agreement, Exhibits
8-K 2019-04-01 Enter Agreement, Exhibits
8-K 2019-02-18 Enter Agreement, Exhibits
8-K 2019-02-05 Enter Agreement, Exhibits
8-K 2019-01-18 Accountant, Exhibits
8-K 2018-12-19 M&A, Exhibits
8-K 2018-12-12 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-10-17 Enter Agreement, Exhibits
8-K 2018-09-30 Enter Agreement
8-K 2018-09-27 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-09-04 Enter Agreement, Off-BS Arrangement, Sale of Shares
8-K 2018-07-16 Other Events, Exhibits
8-K 2018-06-23 Enter Agreement
8-K 2018-05-24 Other Events, Exhibits
8-K 2018-04-18 Other Events, Exhibits
8-K 2018-03-14 Off-BS Arrangement, Other Events, Exhibits
8-K 2018-02-20 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits

Cosmos Holdings Financials

COSM Metrics, Comps, Filings

Quarterly | Annual

Business

Cosmos Holdings Inc. ("us", "we", or the "Company") is a multinational pharmaceutical wholesaler. The Company imports, exports and distributes pharmaceutical products of brand-name and generic pharmaceuticals, over-the-counter (OTC) medicines, a variety of dietary and vitamin supplements. Currently, the Company distributes products mainly in the EU countries via its two wholly owned subsidiaries Skypharm SA and Decahedron Ltd. SkyPharm operates from its facilities in Greece and Decahedron from its facilities in the UK. Most of our business derives from purchasing and reselling branded pharmaceutical products. Large pharmaceutical manufacturers have variable pricing strategies within the EU. The varying prices allow us to source products produced by multi-national pharmaceutical companies in different countries throughout Europe and export them into countries that pay more for those products.

Our core operations were focused on expanding the business of SkyPharm and Decahedron. The Company's focus is primarily on branded pharmaceutical and some generic pharmaceuticals. The Company has also begun to expand into the food supplements industry and has already created its own line of vitamins and food supplement products. The Company plans to also expand its operations into the cosmetic/beauty industry. Through the sale of pharmaceutical products, the Company has created a wide network of pharmaceutical wholesalers and pharmacies that we believe we can utilize to promote and sell our vitamins, food supplements and cosmetic/beauty products. There is growing demand for various food supplements and other cosmetic and beauty products. We plan to serve this demand by offering quality products to our existing network of wholesalers and pharmacies. Pharmacies are still the key channels for distribution and sales of food supplements in the European market.

In addition, we expanded into the full-line wholesale distribution business through the December 2018 acquisition of Cosmofarm Ltd. Full-line pharmaceutical wholesalers provide the local markets with branded pharmaceuticals, generic pharmaceuticals, over-the-counter (OTC) medicines, vitamins, and food supplements. By expanding our pharmaceutical distribution business, we expect to have the ability to source branded and generic products directly from manufacturers and sell vitamins, food supplements, and cosmetic products directly to pharmacies that the full-line wholesalers currently sell. We expect this expansion to increase our sales and profit margins as we vertically integrate into the supply chain.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Axim Biotechnologies (AXIM) 45,833 18% -9.2 -211% 2,377 8,554 513 95 -5,011 -4,838 44,666
Hickok (HICKA) 45,489 22% 4.7 11% 62,836 43,919 89,731 19,505 6,620 10,751 50,895
PayMeOn (PAYM) 45,400 -1,762% -13.7 -131% 2,583 3,294 4 -69 -3,373 -3,295 45,135
Arch Therapeutics (ARTH) 45,130 -9.4 -157% 2,902 3,710 0 0 -4,548 -4,548 42,950
Positive Physicians Holdings (PPHI) 44,543 0% 148.2 -0% 154,581 81,735 20,883 0 -474 174 25,856
Intersections (INTX) 44,437 68% 4.2 25% 37,736 36,881 155,171 105,871 9,357 13,535 56,883
Petroshare (PRHR) 44,347 0% 5.6 -15% 36,928 45,101 16,134 0 -5,501 7,311 40,589
Medicine Man Technologies (MDCL) 44,094 40% -2.1 -38% 35,919 7,979 9,100 3,629 -13,562 -13,517 28,889
Terra Tech (TRTC) 44,034 50% -2.4 -23% 129,806 38,597 25,337 12,769 -29,554 -23,775 57,216
Hoth Therapeutics (HOTH) 44,012 -10.7 -88% 4,335 25 0 0 -3,793 -3,793 40,597
Cosmos Holdings (COSM) 43,856 7% 120.0 -1% 21,280 27,665 36,392 2,689 -183 380 45,596
Gulfslope Energy (GSPE) 43,691 -3.7 -45% 30,784 31,113 0 0 -13,724 -11,439 42,552
Solis Tek (SLTK) 43,678 51% -25.8 -163% 1,378 6,785 1,895 973 -2,244 -1,693 43,612
Where Food Comes From (WFCF) 43,107 42% 21.1 4% 19,538 6,989 15,075 6,341 759 1,882 39,712
CCUR (CCUR) 42,638 0% 7.9 6% 65,998 9,965 5,021 0 4,245 4,508 35,471
Smartag International (SMRN) 42,619 100% -140.1 -347% 87 31 1 1 -304 -304 42,532
Mastermind (MMND) 42,338 88% 91.3 16% 2,419 256 3,727 3,297 375 459 41,906
Newgioco (NWGI) 42,058 0% -17.6 -21% 25,358 17,927 25,127 0 -5,400 -2,117 37,352
Parallax Health Sciences (PRLX) 41,922 280% -5.4 -333% 2,373 7,209 82 229 -7,914 -7,871 42,507
Sanuwave Health (SNWV) 41,781 42% -5.8 -467% 1,644 14,962 693 290 -7,680 -7,149 41,378

Balance Sheet ($'000)2011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Cash40010619501864985841844472851881561984884746207173977801,3527831,3281,1541,2333108871,180
Accounts Receivable1,2286297951264136621,0982,0832,8591,2562,2351,7701,6185,5705,5085,782
Inventory3,480
PP&E1223463951575657537173801151271251251,9502,0432,016
Assets402106195018679872,1047,2207,2356,3646,4236,4806588878902,1063,1194,3917,24910,83510,67613,40513,58319,50621,70621,83021,280
Accounts Payable1093634871,9382,8722,8575,9689,2749,95212,41710,71510,6849,75810,537
Long-Term Debt7751,3112,1152,9192,9192,919
Liabilities661171622703393013591,4049214806781,5261,7611,5601,6131,7141,9052,4172,3423,6704,8716,6269,88013,60213,70417,82517,01316,23125,25026,61427,665
Stockholders' Equity-63-117-160-269-339-295-340-903-545071,4265,6955,4744,8044,8114,766-1,248-1,530-1,452-1,564-1,753-2,235-2,631-2,767-3,028-4,420-3,4313,275-3,545-4,784-6,385
Income Statement ($'000)2011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Revenue09027812,0155,779-1550005341,1369561,4153,2494,1168,8149,54710,23811,96511,2758,5089,6838,5149,686
Cost of Revenue1,0498741,2702,9623,7528,1158,7729,90011,35510,7387,7159,0578,0458,886
Gross Profit8882145287364699775338610702794626469800
R&D
SG&A1605553126186564216-239732251901266110682241251681733283931,4917522,436752773743744904823
Tax0001870000-19891135771000-0001-0-00000000251
Net Income-160-56-55-128-115-58-44-805476141,6224,749-247-109-133-100-6,346-69-114-95-323-2,034-840-198-3,136-3,0567823,207-217-1,540-1,633
Cash Flow ($'000)2011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302019-03-312019-06-302019-09-30
Cash Operating-31-11-12-9-15-511521905177-1326,754-273-175-81-74-16783-146-1,172-891-659-2,676-2,405-3,021-1,867544-639-484-2,307-782
Cash Investing000001818-13-21-1-10-8-1-144837-0-10-41-12-9-459-13067274
Cash Financing197129145612-77-7,0277,532670502121991201,4519733353,1803,1032,6732,376-5161,1911462,1351,185